These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1933642)

  • 1. Gadolinium-enhanced MRI of intracranial lesions. A review of indications and results.
    Wilms G; Marchal G; Demaerel PH; Van Hecke P; Baert AL
    Clin Imaging; 1991; 15(3):153-65. PubMed ID: 1933642
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of MR imaging contrast agents in the brain.
    Bradley WG; Yuh WT; Bydder GM
    J Magn Reson Imaging; 1993; 3(1):199-218. PubMed ID: 8428088
    [No Abstract]   [Full Text] [Related]  

  • 3. Gadolinium-DTPA in magnetic resonance imaging of the brain.
    Valk J; De Slegte RG; Crezee FC; Hazenberg GJ; Thjaha SI
    Neurosurg Rev; 1987; 10(2):87-92. PubMed ID: 3448513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of MR contrast in neoplastic disease of the brain.
    Muroff LR; Runge VM
    Top Magn Reson Imaging; 1995; 7(3):137-57. PubMed ID: 7654393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inverse correlation between T1 relaxation times before and after administration of contrast media in malignant brain tumors.
    Niemi P; Aronen HJ; Kwong KK; Gazit IE; Pardo FS; Rosen BR
    Acad Radiol; 1996 Aug; 3 Suppl 2():S286-8. PubMed ID: 8796582
    [No Abstract]   [Full Text] [Related]  

  • 6. Benefits of Gd-DTPA for MR imaging of intracranial abnormalities.
    Hesselink JR; Healy ME; Press GA; Brahme FJ
    J Comput Assist Tomogr; 1988; 12(2):266-74. PubMed ID: 3351041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetization transfer contrast in Gd-DTPA-enhanced imaging of brain tumors.
    Niemi P; Kurki T; Lundbom N; Kormano M
    Invest Radiol; 1991 Nov; 26 Suppl 1():S248-9; discussion S253-4. PubMed ID: 1808140
    [No Abstract]   [Full Text] [Related]  

  • 8. Indications for the use of Gd-DTPA in MRI of the central nervous system. Experiences in patients with cerebral and spinal diseases.
    Bauer WM; Fenzl G; Vogl T; Fink U; Lissner J
    Invest Radiol; 1988 Sep; 23 Suppl 1():S286-8. PubMed ID: 3198363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spin echo and inversion recovery sequences for gadolinium-DTPA enhanced magnetic resonance imaging of intracranial tumors.
    Laniado M; Niendorf HP; Schörner W; Felix R
    Acta Radiol Suppl; 1986; 369():469-71. PubMed ID: 2980530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Gadolinium dimeglumine gadopentetate compared to CPMG sequencing and image synthesis].
    Higer HP; Just M; Grigat M; Meindl S; Jungke M; Bielke G; Pedrosa P; Kunze S; Voth D
    Rofo; 1988 Mar; 148(3):307-13. PubMed ID: 2832897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dosing of Gd-DTPA in MR imaging of intracranial tumors.
    Schubeus P; Schörner W; Haustein J
    Magn Reson Med; 1991 Dec; 22(2):249-54; discussion 265-7. PubMed ID: 1812354
    [No Abstract]   [Full Text] [Related]  

  • 12. MR contrast enhancement of intracranial lesions with Gd-DTPA.
    Hesselink JR; Press GA
    Radiol Clin North Am; 1988 Jul; 26(4):873-87. PubMed ID: 3289078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Usefulness of MRI with Gd-DTPA in brain tumors].
    Sakamoto Y; Takahashi M; Miyawaki M; Bussaka H; Wakamatsu H
    Rinsho Hoshasen; 1988 Apr; 33(4):435-8. PubMed ID: 3398269
    [No Abstract]   [Full Text] [Related]  

  • 14. Cerebral Erdheim-Chester disease: persistent enhancement with Gd-DTPA on MR images.
    Tien RD; Brasch RC; Jackson DE; Dillon WP
    Radiology; 1989 Sep; 172(3):791-2. PubMed ID: 2772189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrast enhanced magnetic resonance imaging of the brain using gadolinium-DTPA.
    Valk J; de Slegte RG; Crezee FC; Hazenberg GJ; Thjaha SI; Nauta JJ
    Acta Radiol; 1987; 28(6):659-65. PubMed ID: 2962597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Value of contrast enhancement with Gd-DTPA in MRI of brain tumors. A comparison with X-ray CT].
    Tsuji T; Kishikawa T; Ikezaki K; Fujii K; Matsumoto S; Koga T
    Fukuoka Igaku Zasshi; 1987 Dec; 78(12):578-97. PubMed ID: 3447928
    [No Abstract]   [Full Text] [Related]  

  • 17. Cerebral metastatic malignant melanoma: CT and MR findings with pathological correlation.
    Dewulf P; Demaerel P; Wilms G; Delanote G; Defloor E; Casselman J; Baert AL
    J Belge Radiol; 1993 Oct; 76(5):318-9. PubMed ID: 8119873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gd-DTPA: an i.v. contrast agent for clinical MRI.
    Runge VM
    Int J Rad Appl Instrum B; 1988; 15(1):37-44. PubMed ID: 3280522
    [No Abstract]   [Full Text] [Related]  

  • 19. Spin-lock imaging in contrast-enhanced magnetic resonance imaging of human gliomas.
    Aronen HJ; Peltonen TK; Tanttu JI; Sipilä LM; Ruhala MT; Jääskeläinen J; Sepponen R
    Acad Radiol; 1996 Aug; 3 Suppl 2():S170-2. PubMed ID: 8796553
    [No Abstract]   [Full Text] [Related]  

  • 20. Gd-DTPA administered MR imaging of intracranial mass lesions: a comparison with CT and precontrast MR.
    Mihara F; Hirakata R; Hasuo K; Yasumori K; Yoshida K; Kuroiwa T; Masuda K; Fukui M
    Radiat Med; 1989; 7(5):227-35. PubMed ID: 2629036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.